MSCM ventures into RM80BIL healthcare industry


(From left) GeneFlux Bioscience CEO Balaguru Naidu, MSCM Holdings executive chairman Datuk Teoh Hai Hin, MSCM Holdings executive director Jeff Chong, MMA president Dr Ganabaskaran Nadason and MMA honorary general secretary and Koperasi Persatuan Perubatan Malaysia chairman Dr Thirunavukarasu Rajoo at the agreement signing between MSCM Holdings subsidiary HS Bio Supplies and the cooperative on Aug 28,2020.

MSCM Holdings Berhad is venturing into medical supplies and support as it seeks to reduce reliance on its core business and tap into the RM80bil Malaysian healthcare industry.

The group through its subsidiary HS Bio Supplies Sdn Bhd (HSBS) intends to be involved in the business of trading and provision of bio supplies, healthcare products, medical equipment, supplements, test kits, vaccines, among others.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Trading ideas: Binastra, Capital A, Allianz, MN, Vestland, Genting Plantations, YTL Cement, Pimpinan Ehsan, TH Plantations, Marine & General, FGV, SumiSaujana
Energy transition to propel Sarawak’s future
New tech leaves other sectors behind
Indonesia’s domestic investors dominate as FDI falters for 2025
Construction companies poised to�sustain growth
US Federal Reserve vice-chair says interest rates are well positioned
If I were an ageing oil palm tree
Hurdles in DBS’ Alliance Bank bid
Germany proposes giving EV buyers subsidies to boost demand
Metals keep shining bright

Others Also Read